Angiology
Recent studies add new data to angiology research
Published in Gene Therapy Weekly, April 28th, 2005
Study 1: Hypoxia-specific vector-driven gene therapy diminishes tumor angiogenesis.
According to a study from South Korea, "hypoxia-inducible factor-1 (HIF-1) is one of the key mammalian transcription factors and shows increased levels in both protein stability and intrinsic transcriptional activity during low oxygen tension."
"Hypoxia-activated functional HIF-1 protein binds to hypoxia-responsive elements (HRE) in the enhancers of several genes including vascular endothelial growth factor (VEGF), the major player in angiogenesis, and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2005-04-28)
More Articles from Gene Therapy Weekly
- Diabetic Neuropathy
Hepatocyte growth factor gene transfer improves neuropathy in diabetic rats - Gene Transfer
Combined gene therapy regimens demolish cancer proliferation - Lung Cancer
Overexpressed soluble TRAIL initiates the destruction of lung adenocarcinoma - Oncology
Chimeric enhancer controls adenovirus-based prostate cancer gene therapy - Oncology
Silenced insulin-like growth factor binding protein-5 restricts neuroblastoma - Apoptosis
Intracellular overproduction of apolipoprotein L6 induced apoptosis - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
